NCT07275086 (TOHCD-D) is a NA clinical trial of Swedish massage in Diabetes Mellitus, Type 1, sponsored by University Hospital, Linkoeping.

Who is sponsoring NCT07275086?

NCT07275086 is sponsored by University Hospital, Linkoeping.

What drugs are being tested in NCT07275086?

Interventions in NCT07275086: Swedish massage.

What condition does NCT07275086 study?

NCT07275086 studies Diabetes Mellitus, Type 1.

Is NCT07275086 still recruiting?

NCT07275086 is currently not yet recruiting. Last updated 10 December 2025.

Last reviewed 2025-12-10 · How we verify

NCT07275086: TOHCD-D

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Therapeutic Outcomes of Using Complementary Hand-based Treatment in Diabetes

Not yet recruiting NA Last updated 10 December 2025

What this trial tests

NA trial testing Swedish massage in Diabetes Mellitus, Type 1 in 20 participants. Not yet recruiting.

Timeline

1 September 2026

Primary endpoint
1 November 2026

1 February 2027

Quick facts

Lead sponsor	University Hospital, Linkoeping
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	20
Start date	1 September 2026
Primary completion	1 November 2026
Estimated completion	1 February 2027
Sites	1 location across Sweden

Drugs / interventions tested

Swedish massage

Conditions studied

Diabetes Mellitus, Type 1 — all drugs for Diabetes Mellitus, Type 1 →

Sponsor

University Hospital, Linkoeping

Who can join

18 and older, any sex, with Diabetes Mellitus, Type 1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study evaluates potential biological and psychological effects of Swedish massage in adults with type 1 diabetes. Massage may influence stress-related mechanisms, such as hypothalamic-pituitary-adrenal (HPA) axis activity and inflammation, which are linked to impaired insulin sensitivity and glycemic control. Twenty participants with type 1 diabetes will receive weekly 45-60-minute Swedish massage sessions for five weeks. Biological outcomes include HbA1c, fasting glucose, copeptin, hs-CRP, IL-6, and TNF-α. Glycemic variability will be assessed using continuous glucose monitoring (CGM). Psychological outcomes include perceived stress (PSS-10) and anxiety (GAD-7). The study aims to explore feasibility, acceptability, and preliminary within-group effects on stress regulation and glycemic balance

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 1

Currently open trials in the same condition.

NCT07325461 — Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes · NA · recruiting
NCT07305805 — A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes · Phase 1 · recruiting
NCT06282055 — Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes · recruiting
NCT06325202 — Closed Loop and Education for Hypoglycemia Awareness Restoration · NA · recruiting
NCT07160816 — A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar · recruiting

Other University Hospital, Linkoeping trials

Trials by the same sponsor.

NCT07499024 — Evaluation of the Diagnostic Performance of the Testicular Workup for Ischemia and Suspected Torsion (TWIST) Score for A · recruiting
NCT07367776 — Patient Education in Osteoporosis (RCT-PATOS) · NA · recruiting
NCT07211295 — Accurate AI-based Characterisation of Surface Size, Depth and Tissue Composition in Hard-to-Heal Wounds · completed
NCT06869148 — Evaluation of Prioritized Assessment for Older Patients Living With Frailty Presenting to the Emergency Department · completed
NCT06621290 — Patient Experience of CFS-assessment in the ED · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07275086 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Linkoeping
Last refreshed: 10 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07275086.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing